Outcome of transcatheter arterial embolization for bladder and prostate hemorrhage

Anne Delgal1, Jean-Pierre Cercueil, Nicolas Koutlidis

  • 1Division of Urology and Andrology, University of Dijon School of Medicine, Bocage Teaching Hospital, Dijon Cedex, France.

The Journal of Urology
|March 23, 2010
PubMed

Insights

Transcatheter arterial embolization effectively controls intractable bladder and prostate bleeding when conservative treatments fail. This minimally invasive procedure offers a safe alternative to surgery for severely ill patients.

Area of Science:

  • Interventional Radiology
  • Urology
  • Vascular Surgery

Background:

  • Refractory bladder or prostate bleeding poses significant clinical challenges.
  • Conservative management often proves insufficient for life-threatening hemorrhage.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of transcatheter arterial embolization (TAE).
  • To assess TAE as a treatment for intractable bladder or prostate bleeding post-failed conservative therapy.

Main Methods:

  • Retrospective analysis of 20 patients (2 women, 18 men) aged 73 ± 17.2 years.
  • Selective pelvic angiography followed by embolization techniques including superselective distal embolization and proximal coil/particle occlusion.
  • Assessment based on clinical bleeding control and post-embolization angiography.

Main Results:

  • Technical success rate of 90% (18/20 patients).
  • Initial bleeding control achieved in 83.3% (15/18) after the first procedure, with success after repeat procedures in the remaining 3.
  • Periprocedural mortality was 20% (4/20), attributed to underlying conditions; no major catheterization complications.

Conclusions:

  • Selective angiographic embolization is a safe and effective treatment for refractory bladder or prostate bleeding.
  • TAE should be considered the primary treatment, often avoiding the need for emergency surgery in high-risk patients.
Abstract